Anti-IL5 therapies for chronic obstructive pulmonary disease
نویسندگان
چکیده
منابع مشابه
New therapies for chronic obstructive pulmonary disease.
Chronic obstructive pulmonary disease (COPD) is the most common lung disease, carrying a significant mortality and morbidity. None of the therapeutic interventions currently available alter the progression of the disease. As our understanding of the basic mechanisms of alveolar destruction and airflow limitation improves, new targets are identified that may eventually result in treatment option...
متن کاملSurgical therapies for chronic obstructive pulmonary disease.
Surgical procedures for treating emphysema were first developed nearly 100 years ago. Despite a wide range of surgical procedures performed over the years, only three appear to have true clinical benefit: bullectomy, lung volume reduction surgery (LVRS), and lung transplantation. Lung volume reduction surgery has been reintroduced in the past decade and is currently under active research. A rec...
متن کاملNew Therapies for Chronic Obstructive Pulmonary Disease
Chronic obstructive pulmonary disease (COPD) is a major global health problem which is increasing throughout the world and a major cause of death. However, current therapies fail to prevent disease progression or mortality. The mainstay of current drug therapy are long-acting bronchodilators; several longer-acting inhaled 2 -agonists and muscarinic antagonists (and combinations) are now in deve...
متن کاملEvolving therapies in chronic obstructive pulmonary disease
• An estimated three million people die of chronic obstructive pulmonary disease (COPD) every year, and the prevalence of COPD is increasing. By 2020, COPD is expected to become the third-leading cause of death worldwide. • The burden of illness associated with COPD is high. Both the disease itself and common comorbidities, such as cardiovascular disease, asthma, diabetes and mental health prob...
متن کاملNovel therapies in chronic obstructive pulmonary disease
Novel therapies in chronic obstructive pulmonary disease Chronic obstructive pulmonary disease (COPD) continues to be a major medical problem. With no curative therapy being available, management of severe exacerbations of COPD should be directed at relieving symptoms and restoring functional capacity [1]. Mortality from COPD continues to rise and the World Health Organisation predicts it will ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cochrane Database of Systematic Reviews
سال: 2019
ISSN: 1465-1858
DOI: 10.1002/14651858.cd013432